×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • RA CAPITAL MANAGEMENT, L.P. (Data extracted from 13F, 13D, 13G and Form 4)

RA CAPITAL MANAGEMENT, L.P.

AUM: $11.32 B
13-F Portfolio Value: $11.51 B
Last 13-F Filed: Q2 2026
Concentration in top 10: 60.42%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
SYRESPYRE THERAPEUTICS INC-1,621,620Exited13F
ASNDASCENDIS PHARMA A/S - ADR-10,281,496Exited13F
RNAATRIUM THERAPEUTICS INC-864,102Exited13F
CTNMCONTINEUM THERAPEUTICS INC-A-1,296,012Exited13F
DSGNDESIGN THERAPEUTICS INC-2,972,973Exited13F
DNTHDIANTHUS THERAPEUTICS INC-2,611,733Exited13F
FULCFULCRUM THERAPEUTICS INC-6,053,960Exited13F
GRALGRAIL INC-428,266Exited13F
HNGEHINGE HEALTH INC-A-364,613Exited13F
INSPINSPIRE MEDICAL SYSTEMS INC-325,663Exited13F
MPLTMAPLIGHT THERAPEUTICS INC-248,294Exited13F
OLMAOLEMA PHARMACEUTICALS INC-2,600,000Exited13F
PRAXPRAXIS PRECISION MEDICINES I-373,787Exited13F
RLMDRELMADA THERAPEUTICS INC-2,947,369Exited13F
SRPTSAREPTA THERAPEUTICS INC-3,902,596Exited13F
WGSGENEDX HOLDINGS CORP-209,887Exited13F
STROSUTRO BIOPHARMA INC-715,307Exited13F
TVTXTRAVERE THERAPEUTICS INC-746,841Exited13F